查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
患者匹配 AI 臨床試驗解決方案市場規模、份額和趨勢分析報告：按治療用途、最終用途、地區、細分市場預測，2022-2030 年
市場調查報告書
商品編碼
1147574

患者匹配 AI 臨床試驗解決方案市場規模、份額和趨勢分析報告：按治療用途、最終用途、地區、細分市場預測，2022-2030 年

AI-based Clinical Trial Solutions For Patient Matching Market Size, Share & Trends Analysis Report By Therapeutic Application, By End-use, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

患者匹配 AI 臨床試驗解決方案的市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，全球患者匹配 AI 臨床試驗解決方案的市場規模在預測期內將實現 26.7% 的複合年增長率 (CAGR)，到 2030 年將達到 19% . 預計將達到數十億美元。行業增長的主要驅動力是全球慢性病發病率增加、擴大醫療保健部門的投資增加以及新技術的引入。

此外，越來越多地採用基於人工智能 (AI) 的技術進行臨床試驗，以及該領域初創企業的興起也為市場帶來了新的機遇。例如，2022 年 2 月，Qureight 為其基於 AI 的平台籌集了 150 萬美元的種子資金，這將有助於縮短臨床試驗過程的時間，並進一步降低藥物開發成本。領先的生物製藥巨頭正在實施先進的技術解決方案，以改善患者管理和臨床試驗結果。

這些平台進一步縮短了臨床試驗週期時間和成本，並提高了臨床試驗開發的生產力和準確性。基於 AI 的解決方案結合了自然語言處理 (NLP) 算法，以提高臨床試驗和患者註冊之間的匹配率。例如，患者匹配 AI 臨床試驗解決方案使肺癌試驗研究中的患者招募增加了 58.4%。這些優勢進一步推動了市場的增長。

基於治療用途，由於全球癌症患病率上升以及開發癌症治療解決方案的舉措不斷增加，腫瘤學將在 2021 年成為最大的市場。它的市場份額為 23.2%。然而，由於心髒病發作和中風等病例的增加，預計心血管疾病領域在預測期內將呈現最快的增長速度。

按最終用戶劃分，製藥公司的收入份額最高，為 66.0%。這將使製藥行業的主要參與者專注於使用基於 AI 的技術更好地開發生物標誌物和診斷方法來識別新的藥物靶點，從而簡化藥物開發和臨床試驗過程。這是因為

按地區劃分，2021 年北美將佔據 43.8% 的最大市場份額。然而，由於基於 AI 的臨床技術的滲透率不斷提高以及政府對採用 AI 的努力的支持，預計亞太地區在預測期內將呈現最快的增長。

基於人工智能的患者匹配臨床試驗解決方案市場報告要點

2021 年患者匹配 AI 臨床試驗解決方案的全球市場規模為 2.306 億美元，受慢性病患病率上升和臨床試驗過程中基於 AI 技術的日益採用的推動

>

到 2021 年，根據治療用途，腫瘤學將佔最高收入份額，達到 23.2%。全球癌症患病率上升導致臨床試驗數量增加，這對市場產生了積極影響

2021 年，製藥公司在最終用途方面的收入份額最高，為 66.0%。這種增長歸因於在臨床試驗中越來越多地使用基於 AI 的解決方案

由於主要參與者的存在、與生活方式相關的疾病的增加、老年人口的增加以及醫療保健領域進展的擴大，2021 年北美將佔患者匹配 AI 臨床試驗解決方案總量的 43.8%醫療保健領域。

內容

第一章調查方法及範圍

  • 市場細分和範圍
  • 市場定義
  • 調查方法
    • 信息採購
      • 購買的數據庫
      • GVR 內部數據庫
    • 初步調查
  • 調查範圍和假設
  • 數據源列表

第 2 章執行摘要

  • 市場展望
  • 細分市場展望

第 3 章全球患者匹配 AI 臨床試驗解決方案市場變量、趨勢和範圍

  • 描繪滲透率和增長前景
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 患者匹配 AI 臨床試驗解決方案市場分析工具
    • 行業分析 - 搬運工
      • 供應商的議價能力
      • 買家的議價能力
      • 替代威脅
      • 來自新進入者的威脅
      • 競爭公司之間的敵對關係
  • PESTEL 分析
    • 政治形勢
    • 經濟和社會狀況
    • 技術概況
    • 法律狀況
    • 技術概況
  • 對主要交易和戰略聯盟的分析
  • COVID-19 對市場的影響

第 4 章患者匹配 AI 臨床試驗解決方案市場：治療應用估計和趨勢分析

  • 定義和範圍
  • 全球患者匹配 AI 臨床試驗解決方案：治療應用市場份額分析，2021 年和 2030 年
  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病或病症
  • 代謝性疾病
  • 感染
  • 其他

第 5 章患者匹配 AI 臨床試驗解決方案市場：最終用途估計和趨勢分析

  • 定義和範圍
  • 全球患者匹配 AI 臨床試驗解決方案：最終用途市場份額分析，2020 年和 2030 年
  • 製藥公司
  • 學術界
  • 其他

第 6 章患者匹配 AI 臨床試驗解決方案市場：按治療用途和最終用途劃分的區域估計和趨勢分析

  • 全球患者匹配 AI 臨床試驗解決方案：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 意大利
    • 俄羅斯
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第七章公司簡介

  • Unlearn.AI, Inc.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Antidote Technologies, Inc.
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • Deep6.ai
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 孟德爾.ai
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 阿裡斯全球
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 深度鏡頭 AI
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • AmeriSourceBergen 公司
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 科內克薩
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • 微軟公司
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
  • GNS 醫療保健
    • 公司簡介
    • 財務業績
    • 產品基準
    • 戰略舉措
Product Code: GVR-4-68039-982-8

AI-based Clinical Trial Solutions For Patient Matching Market Growth & Trends:

The global AI-based clinical trial solutions for patient matching market size is expected to reach USD 1.9 billion by 2030, registering a compound annual growth rate (CAGR) of 26.7% during the forecast period, according to a new report by Grand View Research, Inc. The major factors attributing the industry growth are the increasing worldwide incidences of chronic diseases, rising investment in the expansion of the healthcare sector, and the introduction of new technologies.

The rising adoption of artificial intelligence(AI)-based technologies for conducting clinical trials and the increasing number of start-ups in this field are also opening new opportunities for the market. For instance, in February 2022, in their seed funding, Qureight raised USD 1.50 million for their AI-based platform which reduces the timeline for the clinical trials process and further helps in reducing the cost of medicine development. Major bio-pharma giants are implementing advanced technological solutions for better patient management and clinical trial results.

These platforms further reduce clinical trial cycle time & cost, thereby increasing productivity & accuracy of the trial development. AI-based solutions incorporate natural language processing (NLP) algorithms which enhances the match rate between clinical trials and patient enrollment. For instance, AI-enabled clinical trial solutions used in matching patients have increased patient recruitment in lung cancer trial studies by 58.4%. Such advantages are further driving the market growth.

Based on therapeutic application, oncology held the largest market share 23.2% in 2021 owing to the rise in the prevalence of cancer all over the globe and rising initiatives to develop therapeutic solutions for oncology. However, the cardiovascular disease segment is expected to show the fastest growth rate during the forecast period owing to increasing cases of heart attack, stroke, and others.

Based on end users, pharmaceutical companies accounted for the highest revenue share of 66.0% owing to the growing focus on better development of bio-markers and diagnostics using AI-based technologies to identify the new medicine target and simplify the process of development of medicine and clinical trials by key players of pharmaceutical companies.

Based on the region North America held the largest market share of 43.8% in 2021. However, Asia Pacific is expected to show the fastest growth rate during the forecast period due to the increasing penetration of AI-based clinical technologies and supportive government initiatives for adopting AI.

AI-based Clinical Trial Solutions For Patient Matching Market Report Highlights:

  • The global AI-based clinical trial solutions for patient matching market size was valued at USD 230.6 million in 2021, owing to the increasing prevalence of chronic diseases and growing adoption of AI-based technologies in the clinical trial process
  • In 2021, based on therapeutic applications, oncology accounted for the highest revenue share of 23.2%. The growing penetration rate of cancer throughout the world is leading to an increase in the number of clinical trials and thus, impacting the market positively
  • In 2021, pharmaceutical companies accounted for the highest revenue share of 66.0% based on end-use. The growth is attributed to the rising usage of AI-based solutions for clinical trials
  • North America dominated the AI-based clinical trial solution for patient matching with 43.8% of the total share in 2021, owing to the presence of key players, increasing prevalence of lifestyle disorders, growing elderly population, and growing advancement in the healthcare sector

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR's internal database
    • 1.3.2 Primary Research
  • 1.4 Research Scope and Assumptions
  • 1.5 List of Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook

Chapter 3 Global AI-based Clinical Trial Solutions for Patient Matching Market Variables, Trends, & Scope

  • 3.1 Penetration and Growth Prospect Mapping
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
  • 3.3 Global AI-based Clinical Trial Solutions for Patient Matching Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
      • 3.3.1.1 Bargaining power of the suppliers
      • 3.3.1.2 Bargaining power of the buyers
      • 3.3.1.3 Threats of substitution
      • 3.3.1.4 Threats from new entrants
      • 3.3.1.5 Competitive rivalry
  • 3.4. PESTEL Analysis
    • 3.4.1 Political landscape
    • 3.4.2 Economic and Social landscape
    • 3.4.3 Technology landscape
    • 3.4.4 Legal landscape
    • 3.4.5 Technology landscape
  • 3.5. Major Deals & Strategic Alliances Analysis
  • 3.6 COVID-19 Impact on the market

Chapter 4 AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Estimates & Trend Analysis

  • 4.1 Definitions & Scope
  • 4.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: Therapeutic Application Market Share Analysis, 2021 and 2030
  • 4.3 Oncology
    • 4.3.1 Oncology analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.4 Cardiovascular Diseases
    • 4.4.1 Cardiovascular Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.5 Neurological Diseases or Conditions
    • 4.5.1 Neurological Diseases or Conditions Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.6 Metabolic Diseases
    • 4.6.1 Metabolic Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.7 Infectious Diseases
    • 4.7.1 Infectious Diseases Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 4.8 Others
    • 4.8.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)

Chapter 5 AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Global AI-based Clinical Trial Solutions for Patient Matching Market: End-Use Market Share Analysis, 2020 and 2030
  • 5.3 Pharmaceutical Companies
    • 5.3.1 Pharmaceutical Companies Analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 5.4 Academia
    • 5.4.1 Academia analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Others analysis Market Estimates and Forecasts, 2016 - 2030 (USD Million)

Chapter 6 AI-based Clinical Trial Solutions for Patient Matching Market: Regional Estimates & Trend Analysis, By Therapeutic Application & End-Use

  • 6.1 Global AI-based Clinical Trial Solutions for Patient Matching Market: Regional Movement Analysis
  • 6.2 North America
    • 6.2.1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts ByTherapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts by Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.4 Spain
      • 6.3.4.1 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.5 France
      • 6.3.5.1 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.6 Italy
      • 6.3.6.1 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.3.7 Russia
      • 6.3.7.1 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.2 China
      • 6.4.2.1 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.3 Japan
      • 6.4.3.1 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates And Forecasts By Therapeutic Application, and End-Use, 2016 - 2030 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Unlearn.AI, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Antidote Technologies, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Deep6.ai
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 Mendel.ai
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 Aris Global
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Deep Lens AI
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 AmeriSourceBergen Corporation
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 Koneksa
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 Microsoft Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 GNS Healthcare
    • 7.10.1 Company Overview
    • 7.10.2 Financial Performance
    • 7.10.3 Product Benchmarking
    • 7.10.4 Strategic Initiatives

List of Tables

  • TABLE 1 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 2 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 3 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 4 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 5 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 6 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 7 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 8 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 9 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 10 U.K. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 11 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 12 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 13 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 14 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 15 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 16 France AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 17 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 18 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 19 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 20 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 21 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 22 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 23 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 24 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 25 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 26 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 27 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 28 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 29 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 30 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 31 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 32 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 33 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 34 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 35 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 36 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 37 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 38 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 39 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 40 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 41 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 42 Middle East & Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 43 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 44 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 45 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 46 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)
  • TABLE 47 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, By Therapeutic Application, 2016 - 2030 (USD Million)
  • TABLE 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, by End-Use, 2016 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 AI-based Clinical Trial Solutions for Patient Matching market snapshot, 2021 (USD Million)
  • FIG. 6 AI-based Clinical Trial Solutions for Patient Matching market trends & outlook
  • FIG. 7 Penetration & growth prospect mapping
  • FIG. 8 Market driver analysis (Current & future impact)
  • FIG. 9 Market restraint analysis (Current & future impact)
  • FIG. 10 AI-based Clinical Trial Solutions for Patient Matching market, therapeutic application outlook key takeaways (USD Million)
  • FIG. 11 AI-based Clinical Trial Solutions for Patient Matching market: therapeutic application movement analysis (USD Million), 2020 & 2030
  • FIG. 12 Oncology Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 13 Cardiovascular diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 14 Neurological Diseases or Conditions Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 15 Metabolic Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 16 Infectious Diseases Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 17 Other Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 18 AI-based Clinical Trial Solutions for Patient Matching market, end-use outlook key takeaways (USD Million)
  • FIG. 19 AI-based Clinical Trial Solutions for Patient Matching market: end-use movement analysis (USD Million), 2020 & 2030
  • FIG. 20 Pharmaceutical companies Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 21 Academia Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 22 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 23 AI-based Clinical Trial Solutions for Patient Matching market, regional outlook key takeaways (USD Million)
  • FIG. 24 AI-based Clinical Trial Solutions for Patient Matching market: Regional movement analysis (USD Million), 2020 & 2030
  • FIG. 25 North America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 26 U.S. AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 27 Canada AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 28 Europe AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 29 U.K AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 30 Germany AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 31 Spain AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 32 France-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 33 Italy AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 34 Russia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 35 Asia Pacific AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 36 China AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 37 Japan AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 38 India AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 39 South Korea AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 40 Australia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 41 Latin America AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 42 Brazil AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 43 Mexico AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 44 Argentina AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 45 MEA AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 46 South Africa AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 47 Saudi Arabia AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)
  • FIG. 48 UAE AI-based Clinical Trial Solutions for Patient Matching Market Estimates and Forecasts, 2016 - 2030 (USD Million)